Back
iShares Emerging Markets Dividend ETF Vs. Bright Minds Biosciences, Inc. Sector Stock Comparison
Sell
46
DVYE
iShares Emerging Markets Dividend ETF
Last Price:
$31.30
Seasonality Move:
-0.16%
Buy
52
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$76.56
Seasonality Move:
-32.54%
Sell
46
iShares Emerging Markets Dividend ETF (DVYE)
is a Sell
Is iShares Emerging Markets Dividend ETF a Buy, Sell or Hold?
-
The current iShares Emerging Markets Dividend ETF [DVYE] share price is $31.07. The Score for DVYE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
DVYE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.12. The Score for DRUG is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DVYE Stock Price Chart
What is iShares Emerging Markets Dividend ETF's stock price today?
-
The iShares Emerging Markets Dividend ETF share price today is $31.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DVYE is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.12The current trend is moderately bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
DVYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.41 | Buy |
| Chaikin Money Flow: | 81730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.69 - 31.25) | Buy |
| Bollinger Bands (100): | (29.53 - 30.97) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 51.07 | Buy |
| Chaikin Money Flow: | -114746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.12 - 86.52) | Buy |
| Bollinger Bands (100): | (43.76 - 72.06) | Buy |
DVYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.83 | Buy |
| 20-day SMA: | 31.01 | Buy |
| 50-day SMA: | 30.83 | Buy |
| 200-day SMA: | 29.08 | Buy |
| 8-day EMA: | 30.96 | Buy |
| 20-day EMA: | 30.95 | Buy |
| 50-day EMA: | 30.73 | Buy |
| 200-day EMA: | 29.42 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.11 | Sell |
| 20-day SMA: | 80.61 | Sell |
| 50-day SMA: | 67.77 | Buy |
| 200-day SMA: | 44.23 | Buy |
| 8-day EMA: | 82.29 | Sell |
| 20-day EMA: | 79.17 | Sell |
| 50-day EMA: | 70.09 | Buy |
| 200-day EMA: | 49.31 | Buy |
iShares Emerging Markets Dividend ETF Earnings Growth & DVYE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.48 per share, and an increase next year of $2.18 per share.
iShares Emerging Markets Dividend ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||